% Options for packages loaded elsewhere
\PassOptionsToPackage{unicode}{hyperref}
\PassOptionsToPackage{hyphens}{url}
\PassOptionsToPackage{dvipsnames,svgnames*,x11names*}{xcolor}
%
\documentclass[
  12pt,
]{memoir}
\usepackage{lmodern}
\usepackage{amssymb,amsmath}
\usepackage{ifxetex,ifluatex}
\ifnum 0\ifxetex 1\fi\ifluatex 1\fi=0 % if pdftex
  \usepackage[T1]{fontenc}
  \usepackage[utf8]{inputenc}
  \usepackage{textcomp} % provide euro and other symbols
\else % if luatex or xetex
  \usepackage{unicode-math}
  \defaultfontfeatures{Scale=MatchLowercase}
  \defaultfontfeatures[\rmfamily]{Ligatures=TeX,Scale=1}
\fi
% Use upquote if available, for straight quotes in verbatim environments
\IfFileExists{upquote.sty}{\usepackage{upquote}}{}
\IfFileExists{microtype.sty}{% use microtype if available
  \usepackage[]{microtype}
  \UseMicrotypeSet[protrusion]{basicmath} % disable protrusion for tt fonts
}{}
\makeatletter
\@ifundefined{KOMAClassName}{% if non-KOMA class
  \IfFileExists{parskip.sty}{%
    \usepackage{parskip}
  }{% else
    \setlength{\parindent}{0pt}
    \setlength{\parskip}{6pt plus 2pt minus 1pt}}
}{% if KOMA class
  \KOMAoptions{parskip=half}}
\makeatother
\usepackage{xcolor}
\IfFileExists{xurl.sty}{\usepackage{xurl}}{} % add URL line breaks if available
\IfFileExists{bookmark.sty}{\usepackage{bookmark}}{\usepackage{hyperref}}
\hypersetup{
  pdftitle={Medicine},
  pdfauthor={Susmit},
  colorlinks=true,
  linkcolor=blue,
  filecolor=Maroon,
  citecolor=Blue,
  urlcolor=red,
  pdfcreator={LaTeX via pandoc}}
\urlstyle{same} % disable monospaced font for URLs
\usepackage[margin=2cm]{geometry}
\usepackage{graphicx}
\makeatletter
\def\maxwidth{\ifdim\Gin@nat@width>\linewidth\linewidth\else\Gin@nat@width\fi}
\def\maxheight{\ifdim\Gin@nat@height>\textheight\textheight\else\Gin@nat@height\fi}
\makeatother
% Scale images if necessary, so that they will not overflow the page
% margins by default, and it is still possible to overwrite the defaults
% using explicit options in \includegraphics[width, height, ...]{}
\setkeys{Gin}{width=\maxwidth,height=\maxheight,keepaspectratio}
% Set default figure placement to htbp
\makeatletter
\def\fps@figure{htbp}
\makeatother
\setlength{\emergencystretch}{3em} % prevent overfull lines
\providecommand{\tightlist}{%
  \setlength{\itemsep}{0pt}\setlength{\parskip}{0pt}}
\setcounter{secnumdepth}{-\maxdimen} % remove section numbering

\title{Medicine}
\author{Susmit}
\date{2022-06-30}

\begin{document}
\frontmatter
\maketitle

\mainmatter
\openany
\raggedbottom
\twocoltocetc
\tableofcontents

\pagebreak

\hypertarget{cardiology}{%
\chapter{Cardiology}\label{cardiology}}

\hypertarget{presenting-problems-in-cvs-disease}{%
\section{Presenting problems in CVS
disease}\label{presenting-problems-in-cvs-disease}}

\hypertarget{features-of-benign-murmur}{%
\subsection{Features of benign murmur}\label{features-of-benign-murmur}}

\begin{itemize}
\tightlist
\item
  Soft
\item
  Midsystolic
\item
  Heard at left sternal edge
\item
  No radiation
\item
  No other cardiac abnormalities
\end{itemize}

\hypertarget{ecg}{%
\section{ECG}\label{ecg}}

\hypertarget{anatomy-of-an-ecg}{%
\subsection{Anatomy of an ECG}\label{anatomy-of-an-ecg}}

\includegraphics[width=0.7\textwidth]{../assets/ecg-anatomy.jpg}

\hypertarget{abnormalities-of-components}{%
\subsection{Abnormalities of
components}\label{abnormalities-of-components}}

\hypertarget{pathological-q}{%
\subsubsection{Pathological Q}\label{pathological-q}}

\begin{itemize}
\tightlist
\item
  Depth \textgreater{} 2mm
\item
  Height \textgreater{} 1mm
\item
  Present in \(\ge\) 2 leads
\item
  Assocd with loss of R height (Q \textgreater{} R/4; normally Q \(\le\)
  R/4)
\item
  \textbf{Indicates \emph{transmural} myocardial necrosis}
\end{itemize}

\hypertarget{segments-vs-intervals}{%
\subsubsection{Segments vs intervals}\label{segments-vs-intervals}}

\begin{itemize}
\tightlist
\item
  e.g.~ST segment = end of S \(\rightarrow\) start of T
\item
  PR interval = start of P \(\rightarrow\) start of R
\end{itemize}

\hypertarget{st-segment-elevation}{%
\subsubsection{ST segment elevation}\label{st-segment-elevation}}

\begin{itemize}
\tightlist
\item
  Normal: upto 1mm in limb leads, upto 2mm in chest leads
\item
  \textbf{Causes}

  \begin{itemize}
  \tightlist
  \item
    \textbf{STEMI:} \textbf{convexity} upwards
  \item
    \textbf{Acute periCArditis:}: \textbf{conCAvity} upwards
  \end{itemize}
\item
  \textbf{Indicates ongoing myocardial injury}
\end{itemize}

\hypertarget{myocardial-infarction}{%
\subsection{Myocardial infarction}\label{myocardial-infarction}}

\href{https://www.cvphysiology.com/CAD/CAD012}{A somewhat interesting
physiological explanation on how the changes arise}

\hypertarget{sites-of-infarction-based-on-lead}{%
\subsubsection{Sites of infarction based on
lead}\label{sites-of-infarction-based-on-lead}}

\begin{itemize}
\tightlist
\item
  Septal: V\(_1\), V\(_2\)
\item
  Anterior: V\(_3\), V\(_4\)
\item
  Lateral: I, aVL, V\(_5\), V\(_6\)
\item
  Extensive anterior: V\(_1\)-V\(_6\)
\item
  Anterolateral: I, aVL, V\(_1\)-V\(_6\)
\end{itemize}

\hypertarget{reciprocal-changes}{%
\subsubsection{Reciprocal changes}\label{reciprocal-changes}}

\begin{itemize}
\tightlist
\item
  Acute STEMI in some surface of the heart \(\rightarrow\) ST elevation
  in corresponding leads, and ST depression in reciprocal leads
\end{itemize}

\includegraphics[width=.7\textwidth]{../assets/reciprocal-leads.jpg}

\hypertarget{basic-pathophys-of-stemi}{%
\subsubsection{Basic pathophys of
STEMI}\label{basic-pathophys-of-stemi}}

\begin{itemize}
\tightlist
\item
  Occurs due to proximal \textbf{complete occlusion of major coronary
  artery}
\end{itemize}

\includegraphics[width=.7\textwidth]{../assets/STEMI.jpg}

\[
\begin{aligned}
&\fbox{A. Before the onset of infarction}\\
&\downarrow\\
&\fbox{B. In acute phase, ST elevation}\\
&\downarrow\\
&\fbox{C. Progressive loss of R and deepening Q}\\
&\downarrow\\
&\fbox{D. Resolution of ST elevation; fully developed pathological Q;
T inversion}\\
&\downarrow\\
&\fbox{E. In old infarcts, T-wave inversion may or may not persist}\\
\end{aligned}
\]

\hypertarget{nstemi}{%
\subsubsection{NSTEMI}\label{nstemi}}

\begin{itemize}
\tightlist
\item
  \textbf{Partial occlusion of major} or \textbf{complete occlusion of
  minor} coronary artery
\item
  \emph{Subendocardial/partial-thickness MI} \(\rightarrow\) no path-Q
\item
  \textbf{ST depression} + \textbf{T inversion} in chest leads
\end{itemize}

\pagebreak

\hypertarget{dermatology}{%
\chapter{Dermatology}\label{dermatology}}

\hypertarget{anatomy-and-physiology}{%
\section{Anatomy and physiology}\label{anatomy-and-physiology}}

\begin{itemize}
\tightlist
\item
  Layers of skin:

  \begin{itemize}
  \tightlist
  \item
    Epidermis: further layered into (from out\(\rightarrow\)in)

    \begin{itemize}
    \tightlist
    \item
      corneum
    \item
      lucidum
    \item
      granulosum
    \item
      spinosum
    \item
      basale
    \end{itemize}
  \item
    Dermis: contains

    \begin{itemize}
    \tightlist
    \item
      blood vessels
    \item
      nerves
    \item
      pilosebaceous units (hair follicle + sebaceous gland)
    \end{itemize}
  \item
    Subcutis: adipose
  \end{itemize}
\end{itemize}

\hypertarget{epidermal-appendages}{%
\subsection{Epidermal appendages}\label{epidermal-appendages}}

\begin{itemize}
\tightlist
\item
  Hair follicles:

  \begin{itemize}
  \tightlist
  \item
    phases of growth

    \begin{itemize}
    \tightlist
    \item
      anagen:

      \begin{itemize}
      \tightlist
      \item
        active growth
      \item
        lasts years in scalp hairs
      \end{itemize}
    \item
      catagen:

      \begin{itemize}
      \tightlist
      \item
        transitional
      \item
        lasts days (in scalp)
      \end{itemize}
    \item
      telogen:

      \begin{itemize}
      \tightlist
      \item
        resting
      \item
        lasts months (in scalp)
      \end{itemize}
    \end{itemize}
  \end{itemize}
\item
  Sebaceous glands

  \begin{itemize}
  \tightlist
  \item
    usually \emph{associated with a hair follicle}
  \item
    \(\fbox{androgens}\rightarrow\) \textbf{\(\uparrow\)}
    \(\fbox{sebum}\)
  \item
    \(\fbox{oestrogen}\rightarrow\) \textbf{\(\downarrow\)}
    \(\fbox{sebum}\)
  \end{itemize}
\item
  Sweat glands

  \begin{itemize}
  \tightlist
  \item
    innerved by \emph{sympathetic cholinergic} fibres
  \end{itemize}
\end{itemize}

\hypertarget{principles-of-management-of-skin-disease}{%
\section{Principles of management of skin
disease}\label{principles-of-management-of-skin-disease}}

\hypertarget{topical-treatments}{%
\subsection{Topical treatments}\label{topical-treatments}}

\begin{itemize}
\tightlist
\item
  Ointments vs Creams

  \begin{itemize}
  \tightlist
  \item
    Ointments preferred to creams for dry skin (e.g.~chronic eczema) as

    \begin{itemize}
    \tightlist
    \item
      more hydrating

      \begin{itemize}
      \tightlist
      \item
        80\% oil + 20\% water in ointments (vs 50-50 for creams)
        \(\rightarrow\) prevent water loss from skin by oil layer
      \end{itemize}
    \item
      less preservatives \(\rightarrow\) less risk of allergy
    \end{itemize}
  \end{itemize}
\item
  Emollients

  \begin{itemize}
  \tightlist
  \item
    Moisturise, lubricate, protect skin
  \item
    \emph{Vehicles without active drug}
  \end{itemize}
\item
  Gluocorticoids
\end{itemize}

\hypertarget{phototherapy}{%
\subsection{Phototherapy}\label{phototherapy}}

\begin{itemize}
\tightlist
\item
  \textbf{UVB}
\item
  \textbf{Psoralen UVA}

  \begin{itemize}
  \tightlist
  \item
    Psoralen:

    \begin{itemize}
    \tightlist
    \item
      natural photosensitiser from plant source
    \item
      cross-link DNA strands on excitation with UVA
    \end{itemize}
  \item
    Cumulative exposure to PUVA \(\rightarrow\;\;\uparrow\) risk of SCC,
    so reserved for UVB resistance
  \end{itemize}
\item
  Uses

  \begin{itemize}
  \tightlist
  \item
    Psoriasis
  \item
    Atopic eczema
  \item
    Vitiligo
  \item
    Chronic urticaria
  \end{itemize}
\end{itemize}

\hypertarget{systemics}{%
\subsection{Systemics}\label{systemics}}

\begin{itemize}
\tightlist
\item
  Antihistamines
\item
  \textbf{Retinoids}

  \begin{itemize}
  \tightlist
  \item
    \emph{Anti-inflammatory}
  \item
    Promote \emph{differentiation of skin cells}
  \item
    \textbf{Teratogenic}

    \begin{itemize}
    \tightlist
    \item
      must be prescribed with robust contraception
    \item
      females must have negative pregnancy test before, during, and
      after therapy
    \end{itemize}
  \end{itemize}
\item
  \textbf{Immunosuppressants}

  \begin{itemize}
  \tightlist
  \item
    Glucocorticoids e.g.~prednisolone
  \item
    Methotrexate
  \item
    Azathioprine
  \end{itemize}
\end{itemize}

\hypertarget{biologics}{%
\subsection{Biologics}\label{biologics}}

\begin{itemize}
\tightlist
\item
  Biological \emph{inhibitors} of \emph{proinflammatory cytokines}
\item
  \textbf{TNF-\(\alpha\) inhibitors}

  \begin{itemize}
  \tightlist
  \item
    Infliximab
  \item
    Etanercept
  \end{itemize}
\item
  \textbf{Interleukin inhibitors}

  \begin{itemize}
  \tightlist
  \item
    Ustekinumab: IL-12, 23
  \item
    Guselkumab: IL-23
  \item
    Secukinumab: IL-17
  \end{itemize}
\item
  \emph{Rituximab}:

  \begin{itemize}
  \tightlist
  \item
    Binds to CD20 \(\rightarrow\) cause ADCC of B cells
  \item
    As terminally differentiated plasma cells don't have CD20 they're
    safe
  \item
    Use: pemphigus vulgaris
  \end{itemize}
\end{itemize}

\hypertarget{non-surgical-therapy}{%
\subsection{Non-surgical therapy}\label{non-surgical-therapy}}

\begin{itemize}
\tightlist
\item
  \textbf{Cryo}

  \begin{itemize}
  \tightlist
  \item
    \emph{Liquid N\(_2\)}
  \item
    Causes cell membrane destruction \(\rightarrow\) death
  \end{itemize}
\item
  Laser
\item
  PDT / photodynamic therapy
\end{itemize}

\hypertarget{skin-cancers}{%
\section{Skin cancers}\label{skin-cancers}}

\hypertarget{classification}{%
\subsection{Classification}\label{classification}}

\begin{itemize}
\tightlist
\item
  Non-melanoma skin cancer (NMSC): most common

  \begin{itemize}
  \tightlist
  \item
    SCC
  \item
    BCC
  \end{itemize}
\item
  Melanoma

  \begin{itemize}
  \tightlist
  \item
    Less common
  \item
    More metastatic risk \(\rightarrow\) cause of most skin cancer
    deaths
  \end{itemize}
\end{itemize}

\hypertarget{fungal-infections}{%
\section{Fungal infections}\label{fungal-infections}}

\hypertarget{types}{%
\subsection{Types}\label{types}}

\begin{itemize}
\tightlist
\item
  Superficial

  \begin{itemize}
  \tightlist
  \item
    Dermatophytes: aka \textbf{ringworm / tineasis}

    \begin{itemize}
    \tightlist
    \item
      \emph{Trichophyton}
    \item
      \emph{Epidermophyton}
    \item
      \emph{Microsporum}
    \end{itemize}
  \item
    Yeast
  \end{itemize}
\item
  Deep: less common

  \begin{itemize}
  \tightlist
  \item
    Chromomycosis
  \item
    Sporotrichosis
  \end{itemize}
\end{itemize}

\hypertarget{scabies}{%
\section{Scabies}\label{scabies}}

\hypertarget{agent}{%
\subsection{Agent}\label{agent}}

Caused by the mite \emph{Sarcoptis scabies hominis}

\hypertarget{diagnosis}{%
\subsection{Diagnosis}\label{diagnosis}}

\begin{itemize}
\tightlist
\item
  Identify the skin burrow
\item
  Visualize the mite by dermatoscope / extracting with a needle
\end{itemize}

\hypertarget{treatment}{%
\subsection{Treatment}\label{treatment}}

\begin{itemize}
\tightlist
\item
  Affected + all asymptomatic family members / physical contacts
\item
  Topical permethrin / malathion

  \begin{itemize}
  \tightlist
  \item
    2 applications
  \item
    1 wk apart
  \item
    Whole body, except head
  \end{itemize}
\item
  Oral Ivermectin:

  \begin{itemize}
  \tightlist
  \item
    Single dose
  \item
    For poor adherence, immunosuppresion or heavy infestation
  \end{itemize}
\end{itemize}

\hypertarget{acne}{%
\section{Acne}\label{acne}}

\begin{itemize}
\tightlist
\item
  \emph{Chronic inflammation} of \emph{pilosebaceous} units
\end{itemize}

\hypertarget{pathogenesis}{%
\subsection{Pathogenesis}\label{pathogenesis}}

Key components are:

\begin{itemize}
\tightlist
\item
  \(\uparrow\) Sebum production
\item
  Colonisation of pilosebaceous ducts by \emph{Propionibacterium acnes}
\item
  Occlusion of pilosebaceous ducts
\end{itemize}

\hypertarget{features}{%
\subsection{Features}\label{features}}

\begin{itemize}
\tightlist
\item
  Hallmark: \textbf{comedone}
\item
  Greasiness of skin
\end{itemize}

\hypertarget{management}{%
\subsection{Management}\label{management}}

\begin{itemize}
\tightlist
\item
  \textbf{Mild disease}

  \begin{itemize}
  \tightlist
  \item
    Topical Benzoyl peroxide
  \item
    Topical Retinoids
  \item
    Topical antibiotics

    \begin{itemize}
    \tightlist
    \item
      Erythromycin
    \item
      Clindamycin
    \end{itemize}
  \end{itemize}
\item
  \textbf{Moderate disease}: topical \emph{plus}

  \begin{itemize}
  \tightlist
  \item
    Systemic tetracycline
  \item
    Oestrogen containing OCP
  \item
    Isotretinoin: if inadequate response to topical+systemic therapy for
    6 months
  \end{itemize}
\item
  \textbf{Severe disease}

  \begin{itemize}
  \tightlist
  \item
    Isotretinoin 0.5-1 mg/kg for 4 months:

    \begin{itemize}
    \tightlist
    \item
      Reduce sebum secretion and follicle colonisation
    \item
      Teratogen
    \item
      Pregnancy must be avoided during treatment \emph{and} within 2 mo
      of drug cessation
    \end{itemize}
  \item
    Systemic glucocorticoid (with isotretinoin)
  \item
    If unable to use isotretinoin

    \begin{itemize}
    \tightlist
    \item
      UVB phototherapy
    \item
      PDT
    \end{itemize}
  \end{itemize}
\end{itemize}

\pagebreak

\hypertarget{eczemas}{%
\section{Eczemas}\label{eczemas}}

\begin{itemize}
\tightlist
\item
  Seborrhoeic dermatitis is associated with \emph{Malassezia} yeasts
\end{itemize}

\hypertarget{features-1}{%
\subsection{Features}\label{features-1}}

Most types have the following clinical features:

\hypertarget{acute}{%
\subsubsection{Acute}\label{acute}}

\begin{itemize}
\tightlist
\item
  Ill-defined erythema, oedema
\item
  Papules, vesicles, bullae
\item
  Exudation
\item
  Scaling
\end{itemize}

\hypertarget{chronic}{%
\subsubsection{Chronic}\label{chronic}}

\begin{itemize}
\tightlist
\item
  Above features
\item
  Lichenification

  \begin{itemize}
  \tightlist
  \item
    Skin thickening with pronounced skin markings, 2\(^\circ\) to
    chronic scratching
  \item
    Fissures
  \item
    Dyspigmentation
  \end{itemize}
\end{itemize}

\hypertarget{management-of-eczema}{%
\subsection{Management of eczema}\label{management-of-eczema}}

\includegraphics[width=.8\textwidth]{../assets/eczema.jpg}

\pagebreak

\hypertarget{psoriasis}{%
\section{Psoriasis}\label{psoriasis}}

\begin{itemize}
\tightlist
\item
  Chronic inflammatory hyperproliferative skin disease
\item
  \textbf{Characteristics}

  \begin{itemize}
  \tightlist
  \item
    \textbf{Well-defined erythematous scaly plaques}
  \item
    Affecting \textbf{extensor surfaces, scalp, nails}
  \end{itemize}
\end{itemize}

\hypertarget{histological-features}{%
\subsection{Histological features}\label{histological-features}}

\begin{itemize}
\tightlist
\item
  Keratinocyte hyperproliferation + abnormal differentiation
  \(\rightarrow\) nucleated stratum corneum cells (transit time from
  basale to corneum reduced to 5 from 28 \(\rightarrow\) keratinocytes
  reach the surface while immature)
\item
  Inflammation with Th-1 and Th-17 infiltration
\item
  Tortuosity of dermal capillaries and release of VEGF
\end{itemize}

\hypertarget{exacerbating-factors}{%
\subsection{Exacerbating factors}\label{exacerbating-factors}}

\begin{itemize}
\tightlist
\item
  \textbf{Sunlight}
\item
  \textbf{Trauma}
\item
  \textbf{Infection}

  \begin{itemize}
  \tightlist
  \item
    \(\beta\)-haemolytic strep \(\uparrow\) guttate psoriasis
  \item
    HIV may initally present with severe psoriasis
  \end{itemize}
\item
  \textbf{Drugs}

  \begin{itemize}
  \tightlist
  \item
    Antimalarials
  \item
    \(\beta\)-blockers
  \item
    Lithium
  \item
    NSAIDs
  \end{itemize}
\item
  \textbf{Stress and anxiety}
\end{itemize}

\hypertarget{clinical-types}{%
\subsection{Clinical types}\label{clinical-types}}

\begin{itemize}
\tightlist
\item
  \textbf{Plaque} psoriasis:

  \begin{itemize}
  \tightlist
  \item
    most common
  \item
    well-demarcated erythematous plaques
  \item
    silver-white scales in untreated

    \begin{itemize}
    \tightlist
    \item
      bleed on scraping (due to dilated vessels underneath)
      \(\rightarrow\) \textbf{Auspitz sign}
    \end{itemize}
  \item
    \textbf{Sites}

    \begin{itemize}
    \tightlist
    \item
      extensor surfaces

      \begin{itemize}
      \tightlist
      \item
        elbows
      \item
        knees
      \item
        lower back
      \end{itemize}
    \item
      scalp
    \item
      nails
    \end{itemize}
  \end{itemize}
\item
  \textbf{Guttate} psoriasis:

  \begin{itemize}
  \tightlist
  \item
    follows \emph{Strep} throat
  \item
    common in children/adolescent
  \item
    UVB highly effective
  \item
    may herald the onset of plaque psoriasis in adulthood
  \end{itemize}
\item
  \textbf{Erythrodermic} sporiasis: generalised \(\rightarrow\) medical
  emergency
\item
  \textbf{Pustular} psoriasis
\end{itemize}

\hypertarget{management-of-psoriasis}{%
\subsection{Management of psoriasis}\label{management-of-psoriasis}}

\includegraphics[width=.85\textwidth]{../assets/psoriasis.jpg}

\pagebreak

\hypertarget{hypopigmentation}{%
\section{Hypopigmentation}\label{hypopigmentation}}

\hypertarget{causes}{%
\subsection{Causes}\label{causes}}

\begin{itemize}
\tightlist
\item
  Vitiligo
\item
  Albinism
\item
  Pityriasis alba
\item
  Pityriasis versicolor
\end{itemize}

\hypertarget{vitiligo}{%
\subsection{Vitiligo}\label{vitiligo}}

\begin{itemize}
\tightlist
\item
  \textbf{Acquired}
\item
  Cell-mediated \textbf{autoimmune destruction of melanocytes}
\item
  Loss of melanocytes \(\rightarrow\) hypopigmented patches
\end{itemize}

\hypertarget{albinism}{%
\subsection{Albinism}\label{albinism}}

\begin{itemize}
\tightlist
\item
  \textbf{Autosomal recessive}
\item
  \textbf{Reduced melanin production} by \textbf{normal number of
  melanocytes}
\item
  \(\uparrow\uparrow\) risk of sunburn, skin cancer
\end{itemize}

\hypertarget{hyperpigmentation}{%
\section{Hyperpigmentation}\label{hyperpigmentation}}

\hypertarget{causes-1}{%
\subsection{Causes}\label{causes-1}}

\begin{itemize}
\tightlist
\item
  \textbf{Endocrine}

  \begin{itemize}
  \tightlist
  \item
    Melasma/chloasma:

    \begin{itemize}
    \tightlist
    \item
      in pregnancy / some OCP users
    \item
      discrete patches of facial pigmentation
    \end{itemize}
  \item
    Addison's disease
  \item
    Cushing's syndrome
  \item
    Nelson's syndrome

    \begin{itemize}
    \tightlist
    \item
      hyper-ACTH 2\(^\circ\) to bilateral adrenalectomy for Cushing's
    \item
      due to loss of -ve feedback from plasma cortisol
    \end{itemize}
  \item
    CKD
  \end{itemize}
\item
  \textbf{Drugs}

  \begin{itemize}
  \tightlist
  \item
    Amiodarone
  \item
    Anti-cancers:

    \begin{itemize}
    \tightlist
    \item
      Bleomycin: Hodgkin's
    \item
      Busulfan: CML
    \end{itemize}
  \item
    Choroquine
  \item
    Psoralens
  \end{itemize}
\end{itemize}

\hypertarget{pseudorandom-factoids}{%
\section{Pseudorandom factoids}\label{pseudorandom-factoids}}

\hypertarget{spf-sun-protection-factor}{%
\subsection{SPF (sun protection
factor)}\label{spf-sun-protection-factor}}

\begin{itemize}
\tightlist
\item
  \(\frac{\LARGE{\text{UV dose for producing erythema with sunscreen}}} {\LARGE{\text{UV dose for producing erythema without sunscreen}}}\)
\end{itemize}

\hypertarget{mechanism-of-venous-ulceration}{%
\subsection{Mechanism of venous
ulceration}\label{mechanism-of-venous-ulceration}}

\begin{center}
\fbox{Incompetent valves} \\
$\downarrow$ \\
\fbox{$\uparrow$ capillary pressure} \\
$\downarrow$ \\
\fbox{Fibrinogen leaks out of capillary} \\
$\downarrow$ \\
\fbox{Forms fibrin clot around capillary (pericapillary cuffing)} \\
$\downarrow$ \\
\fbox{Impaired diffusion from capillaries} \\
$\downarrow$ \\
\fbox{Impaired oxygenation}
\end{center}

\pagebreak

\hypertarget{neurology}{%
\chapter{Neurology}\label{neurology}}

\hypertarget{raised-icp}{%
\section{Raised ICP}\label{raised-icp}}

\begin{itemize}
\tightlist
\item
  Normal ICP = \textbf{5-15 mmHg}
\end{itemize}

\hypertarget{causes-2}{%
\subsection{Causes}\label{causes-2}}

\begin{itemize}
\tightlist
\item
  \textbf{ICSOL}

  \begin{itemize}
  \tightlist
  \item
    Intracranial haemorrhage
  \item
    Tumours e.g.~glioma
  \item
    Brain abscess
  \end{itemize}
\item
  \textbf{Hydrocephalus}: blockade of CSF circulation

  \begin{itemize}
  \tightlist
  \item
    Obstructive / non-communicating
  \item
    Communicating
  \end{itemize}
\item
  \textbf{Cerebral oedema} e.g.~meningoencephilitis
\item
  \textbf{Venous sinus obstruction} e.g.~cerebral venous thrombosis
\end{itemize}

\hypertarget{features-2}{%
\subsection{Features}\label{features-2}}

\begin{itemize}
\tightlist
\item
  \textbf{Headache}
\item
  \textbf{Vomiting}
\item
  \textbf{Diplopia / blurred vision}: Due to \emph{6th nerve palsy}

  \begin{itemize}
  \tightlist
  \item
    6th nerve palsy due to

    \begin{itemize}
    \tightlist
    \item
      stretching of the long, slender nerve
    \item
      compression against petrous temporal bone
    \end{itemize}
  \end{itemize}
\item
  \textbf{Papilloedema}
\item
  \textbf{Bradycardia}
\item
  \textbf{Hypertension}
\item
  \textbf{Depressed consciousness}
\end{itemize}

\hypertarget{management-1}{%
\subsection{Management}\label{management-1}}

\begin{itemize}
\tightlist
\item
  According to cause:

  \begin{itemize}
  \tightlist
  \item
    Mass lesion \(\rightarrow\) surgical decompression
  \item
    Hydrocephalus \(\rightarrow\) \emph{ventriculoperitoneal shunt}
    operation
  \item
    Oedema \(\rightarrow\) glucocorticoids
  \end{itemize}
\item
  Supportive:

  \begin{itemize}
  \tightlist
  \item
    Head elevation
  \item
    Fluid balance
  \item
    BP control
  \item
    Diuretics: mannitol
  \end{itemize}
\end{itemize}

\hypertarget{neurological-emergencies}{%
\section{Neurological emergencies}\label{neurological-emergencies}}

\begin{itemize}
\tightlist
\item
  \textbf{Status epilepticus}
\item
  \textbf{Stroke} (if thrombo)
\item
  \textbf{Subarachnoid haemorrhage}
\item
  \textbf{Cord compression}
\item
  \textbf{GBS}
\item
  \textbf{Myasthenia gravis} (if bulbar and/or respiratory)
\end{itemize}

\backmatter
\end{document}
